In a recent study independent of quantitative radiographic analysis of interstitial lung disease or fibrosis, tocilizumab successfully stabilized forced vital capacity (FVC) over 48 weeks in patients with early systemic sclerosis...
In a recent study independent of quantitative radiographic analysis of interstitial lung disease or fibrosis, tocilizumab successfully stabilized forced vital capacity (FVC) over 48 weeks in patients with early systemic sclerosis...
In a recent study independent of...